EP2240188A1 - Ointment on the basis of a dialysate of calves' blood. - Google Patents

Ointment on the basis of a dialysate of calves' blood.

Info

Publication number
EP2240188A1
EP2240188A1 EP08706951A EP08706951A EP2240188A1 EP 2240188 A1 EP2240188 A1 EP 2240188A1 EP 08706951 A EP08706951 A EP 08706951A EP 08706951 A EP08706951 A EP 08706951A EP 2240188 A1 EP2240188 A1 EP 2240188A1
Authority
EP
European Patent Office
Prior art keywords
ointment
skin
alpha
delta
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP08706951A
Other languages
German (de)
French (fr)
Other versions
EP2240188A4 (en
Inventor
Mohamed Hamdi Hasan Badrawi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of EP2240188A1 publication Critical patent/EP2240188A1/en
Publication of EP2240188A4 publication Critical patent/EP2240188A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/983Blood, e.g. plasma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth

Definitions

  • Topical retinoid Derived from vitamin A, retinoid that you apply to the skin may be able to reduce fine wrinkles, splotchy pigmentation and skin roughness. Retinoid must be used with a skin-care program that includes sunscreen and protective clothing because the medication can make the skin bum more easily. It may also cause redness, dryness, itching, and a burning or tingling sensation.
  • Nonprescription wrinkle creams The effectiveness of anti-wrinkle creams depends in part on the active ingredient or ingredients. Retinol, alpha hydroxy acids, kinetin, coenzyme QlO, copper peptides and antioxidants may result in slight to modest improvements in wrinkles. Surgical procedures and other techniques
  • Microdermabrasion This technique is similar to dermabrasion, but less surface skin is removed. It's done using a vacuum suction over the face while aluminum oxide crystals essentially sandblast the skin. Microdermabrasion usually requires repeated treatments to maintain the subtle, temporary results.
  • Laser, light source and radio frequency treatments In laser resurfacing, a laser beam destroys the outer layer of skin (epidermis) and heats the underlying skin (dermis), which stimulates the growth of new collagen fibers. As the wound heals, new skin forms that's smoother and tighter. It can take up to several months to fully heal from laser resurfacing. Less intense lasers (nonablative lasers), pulsed light sources and radio frequency devices don't injure the epidermis. These treatments heat the dermis and cause new collagen and elastin formation. After several treatments, skin feels firmer and appears refreshed. This means shorter recovery times, but treatment typically needs to be repeated more often and results are subtle.
  • Botulinum toxin type A Botox
  • Botox When injected in small doses into specific muscles, Botox blocks the chemical signals that cause muscles to contract. When the muscles can't tighten, the skin flattens and appears smoother and less wrinkled. Botox works well on frown lines between the eyebrows and across the forehead, and crow's-feet at the corners of the eyes. Results typically last about three to four months. Repeat injections are needed to maintain results.
  • Soft tissue fillers which include fat, collagen and hyaluronic acid , can be injected into deeper wrinkles on your face. They plump and smooth out wrinkles and furrows and give the skin more volume. The procedure may need to be repeated every few months.
  • Face-lift The face-lift procedure involves removing excess skin and fat in the lower face and neck and tightening the underlying muscle and connective tissue. The results typically last five to 10 years. Healing times can be lengthy after a face-lift. Bruising and swelling are usually evident for two to three weeks after surgery.
  • A- Wrinkles are a natural part of aging, skin gets thinner, drier and less elastic. And it becomes less able to protect itself from damage. As a result, wrinkles, lines and creases form in the skin. Although genetics are the most important determiner of skin texture, a major contributor to wrinkles is spending too much time in the sun. Smoking also can negatively affect how the skin looks.
  • Wrinkles are caused by a combination of factors:
  • UV light Exposure to ultraviolet (UV) light.
  • UV light breaks down the skin's connective tissue — collagen and elastin fibers, which lie in the deeper layer of skin (dermis). Without the supportive connective tissue, the skin loses its strength and flexibility. As a result, skin begins to sag and wrinkle prematurely.
  • Smoking can accelerate the normal aging process of the skin, contributing to wrinkles. This may be due to changes in the blood supply to the skin around the lips.
  • B-A new ointment in two concentration composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added:
  • Substance 1 vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-).
  • Alpha-tocopherol is the only form of vitamin E that is actively maintained in the human body and is therefore, the form of vitamin E found in the largest quantities in the blood and tissue.
  • the fat-soluble vitamin, alpha-tocopherol is uniquely suited to intercepting free radicals and preventing a chain reaction of lipid destruction. Aside from maintaining the integrity of cell membranes throughout the body, alpha-tocopherol also protects the fats in low density lipoproteins (LDLs) from oxidation.
  • LDLs low density lipoproteins
  • Substance 2 Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml. It is a tissue metabolism activator, chemically and biologically standardized - deproteinised, non antigenic and apyrogenic hemodialized extract form the blood of healthy young calf. It contains large amounts of natural low molecular weight substances - glycolipides, nucleosides, nucleotides, amino acids, oligopeptides, irreplaceable microelements, electrolytes, intervening products of carbohydrate and fat metabolism.
  • the low concentration SE CARE ointment has the ability of revitalize skin and abolishing skin wrinkling significantly
  • the high concentration SE CARE ointment has the ability to promote scalp hair growth and healing of persistent ulcers.
  • Ointment base (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added: a-Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitaminE ⁇ and o. lgm of subtance2 (Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml) a new ointment are created (SE CAREl) which when applied once daily on the skin has the ability to revitalize the skin and reduce the skin wrinkles significantly within three month.
  • SE CAREl composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added: a-Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitaminE ⁇ and o. lgm of subt
  • A-Ointment base (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added
  • B- substance 1 vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-).
  • C- substance2 Protein-free haemodialysate of calves 1 blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml
  • Manufactured To Be Used as a topical treatment has the ability to revitalized the skin and reduce the skin wrinkles significantly, the ability to promote healing of persistent ulcer and to stimulate scalp hair growth.

Abstract

The present invention refers to an ointment comprising vitamin E in particular alpha- tocopherol and a protein-free haemodialysate, chemically and biologically standardized - from the blood of healthy young calves. It stimulates cellular oxygen consumption, stimulates ATP synthesis, and accelerates regeneration in reversible cell and prevents tissue damage as well as promotes revascularization of ischemic tissue, promote collagen synthesis and growth of new granulation tissue, and accelerates revitalization. As carrier the ointment contains vaseline (70%) in oily solution. Low concentrated ointment have the ability to revitalize the skin and decrease wrinkles. The high concentrated ointment have the ability to stimulate hair growth and promote healing of persisting ulcers.

Description

A NEW OINTMENT TO REVITALIZE SKIN AND PROMOTE HEALING OF ULCERS
Technical Field:
Skin wrinkles especially on the face and neck together with scalp hair loss constitute a problem in human species with advanced age. Many procedures either medical or surgical where described to treat such cases with different success rate, but still the field contained plenty of spaces for new medications and procedures.
Also persistent ulcer may constitute a problem in finding the proper treatment. Effective method for treatment constitutes a good advantage for such cases.
Background, Art,
Many types of surgical procedures, and also different topical medications were used to counteract the aging effect on the skin (wrinkling, dryness).
Medications:
• Topical retinoid. Derived from vitamin A, retinoid that you apply to the skin may be able to reduce fine wrinkles, splotchy pigmentation and skin roughness. Retinoid must be used with a skin-care program that includes sunscreen and protective clothing because the medication can make the skin bum more easily. It may also cause redness, dryness, itching, and a burning or tingling sensation.
• Nonprescription wrinkle creams. The effectiveness of anti-wrinkle creams depends in part on the active ingredient or ingredients. Retinol, alpha hydroxy acids, kinetin, coenzyme QlO, copper peptides and antioxidants may result in slight to modest improvements in wrinkles. Surgical procedures and other techniques
A variety of skin resurfacing techniques, injectables, fillers and surgical procedures are available to smooth out wrinkles. Each works a little differently and has its own set of potential results and side effects.
• Dermabrasion. This procedure consists of sanding down (planing) the surface layer of the skin with a rapidly rotating brush. The planing removes the skin surface and a new layer of skin grows in its place. Redness, scabbing and swelling generally last a couple of weeks. It may take several months for the pinkness to fade and to see the desired results.
• Microdermabrasion. This technique is similar to dermabrasion, but less surface skin is removed. It's done using a vacuum suction over the face while aluminum oxide crystals essentially sandblast the skin. Microdermabrasion usually requires repeated treatments to maintain the subtle, temporary results.
• Laser, light source and radio frequency treatments. In laser resurfacing, a laser beam destroys the outer layer of skin (epidermis) and heats the underlying skin (dermis), which stimulates the growth of new collagen fibers. As the wound heals, new skin forms that's smoother and tighter. It can take up to several months to fully heal from laser resurfacing. Less intense lasers (nonablative lasers), pulsed light sources and radio frequency devices don't injure the epidermis. These treatments heat the dermis and cause new collagen and elastin formation. After several treatments, skin feels firmer and appears refreshed. This means shorter recovery times, but treatment typically needs to be repeated more often and results are subtle.
• Chemical peel. By application of an acid to the affected areas, which burns the outer layer of your skin. With medium-depth peels, the entire epidermis and a small portion of the dermis are removed. New skin forms to take its place. The new skin is usually smoother and less wrinkled than the old skin. Redness lasts up to several months. With superficial peels, only a portion of the epidermis is removed. After a series of peels, less fine wrinkling may be noticed in the skin and a fading of brown spots. • Botulinum toxin type A (Botox). When injected in small doses into specific muscles, Botox blocks the chemical signals that cause muscles to contract. When the muscles can't tighten, the skin flattens and appears smoother and less wrinkled. Botox works well on frown lines between the eyebrows and across the forehead, and crow's-feet at the corners of the eyes. Results typically last about three to four months. Repeat injections are needed to maintain results.
• Soft tissue fillers. Soft tissue fillers, which include fat, collagen and hyaluronic acid , can be injected into deeper wrinkles on your face. They plump and smooth out wrinkles and furrows and give the skin more volume. The procedure may need to be repeated every few months.
• Face-lift. The face-lift procedure involves removing excess skin and fat in the lower face and neck and tightening the underlying muscle and connective tissue. The results typically last five to 10 years. Healing times can be lengthy after a face-lift. Bruising and swelling are usually evident for two to three weeks after surgery.
Although surgical procedures are numerous and succefull yet it still carries the disadvantages and complications of surgery and may has to be repeated.
Local applications such as ointments, creams, lotions are many with different mode of actions. Still this field is still opened for more new ideas.
Whenever a new substance is created and proved to be effective and without any harmful complications, it will be considered as good scientific addition to the field reconstruction.
Wounds and ulcers of the skin are another field which needs new substances to promote healing.
DISCLOSURE OF INVENTION:
A- Wrinkles are a natural part of aging, skin gets thinner, drier and less elastic. And it becomes less able to protect itself from damage. As a result, wrinkles, lines and creases form in the skin. Although genetics are the most important determiner of skin texture, a major contributor to wrinkles is spending too much time in the sun. Smoking also can negatively affect how the skin looks.
Wrinkles are caused by a combination of factors:
• Age. Getting older, the skin naturally became thins and less elastic and more fragile. Decreased production of natural oils makes the skin drier and more wrinkled. Fat in the deeper layers of the skin, which gives the skin a plump appearance, starts to lessen. This causes loose, saggy skin and more pronounced lines and crevices.
• Exposure to ultraviolet (UV) light. Ultraviolet radiation speeds up the natural aging process and is the primary cause of early wrinkling. Exposure to UV light breaks down the skin's connective tissue — collagen and elastin fibers, which lie in the deeper layer of skin (dermis). Without the supportive connective tissue, the skin loses its strength and flexibility. As a result, skin begins to sag and wrinkle prematurely.
• Smoking. Smoking can accelerate the normal aging process of the skin, contributing to wrinkles. This may be due to changes in the blood supply to the skin around the lips.
B-A new ointment (SE CARE) in two concentration composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added:
Substance 1 : vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-). Alpha-tocopherol is the only form of vitamin E that is actively maintained in the human body and is therefore, the form of vitamin E found in the largest quantities in the blood and tissue. The main function of alpha-tocopherol in humans appears to be that of an antioxidant. Free radicals are formed primarily in the body during normal metabolism and also upon exposure to environmental factors such as cigarette smoke or pollutants. Fats, which are an integral part of all cell membranes, are vulnerable to destruction through oxidation by free radicals. The fat-soluble vitamin, alpha-tocopherol, is uniquely suited to intercepting free radicals and preventing a chain reaction of lipid destruction. Aside from maintaining the integrity of cell membranes throughout the body, alpha-tocopherol also protects the fats in low density lipoproteins (LDLs) from oxidation.
Substance 2: Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml. It is a tissue metabolism activator, chemically and biologically standardized - deproteinised, non antigenic and apyrogenic hemodialized extract form the blood of healthy young calf. It contains large amounts of natural low molecular weight substances - glycolipides, nucleosides, nucleotides, amino acids, oligopeptides, irreplaceable microelements, electrolytes, intervening products of carbohydrate and fat metabolism. It stimulates cellular oxygen consumption by increasing the oxygen uptake of mitochondria , especially in cases of hypoxia, normalizes metabolism, glucose transport, stimulates ATP synthesis, and accelerates regeneration in reversible cell and tissue damage. Stimulates angiogenesis, promotes revascularization of ischemic tissue, creation of conditions for collagen synthesis and growth of new granulation tissue, and accelerates revitalization and wound coverage. Possesses membrane-stabilizing and cell- protecting properties.
C- the low concentration SE CARE ointment has the ability of revitalize skin and abolishing skin wrinkling significantly, the high concentration SE CARE ointment has the ability to promote scalp hair growth and healing of persistent ulcers.
THE INVENTION:
Ointment base: (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added: a-Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitaminE} and o. lgm of subtance2 (Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml) a new ointment are created (SE CAREl) which when applied once daily on the skin has the ability to revitalize the skin and reduce the skin wrinkles significantly within three month. b- Adding to every lOOgm of the base ointment 1 gm of substance 1 (vitamin E) and 0.5gm of substance2 (Protein-free haemodialysate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml) a new ointment (SE CARE 2) were created which when applied once daily on the skin has the ability to promote healing of persistent ulcer in two weeks and the ability to stimulate scalp hair growth in thee month significantly.
FORMULA:
A-Ointment base: (SE CARE) composed of 70% Vaseline in oily solution (paraffin, almond oil, bees wax, perfume) as a base to which two substances were added
B- substance 1 : vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-).
C- substance2: Protein-free haemodialysate of calves1 blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml
UTILITY USE:
The New Ointment SE Care 1 And SE Care2 Could Industrialy
Manufactured To Be Used as a topical treatment has the ability to revitalized the skin and reduce the skin wrinkles significantly, the ability to promote healing of persistent ulcer and to stimulate scalp hair growth.

Claims

Claims
1- Two Different Substances:
A- Vitamin E( a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-) stated as substance 1.
B-Protein-free haemodialy sate of calves' blood (Bos Taurus) chemically and biologically standardized 42.5 mg/ml stated as Substance2.
When used together in a topical preparation has The Ability To Revitalize The Skin, Decrease The Wrinkles, Stimulate Hair Growth In Three Months Time And Promote Healing Of Persistant Ulcer In Two Weeks Time.
2-The New Ointment (SE Carel) The Low Concentration Version Formed By Adding Two Substanses, Substance 1 Which Is lgm Vitamin E Describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-),Substance2 Which Is 0,lgm Protein-free haemodialysate of calves' blood (Bos Taurus)chemically and biologically standardized 42.5 mg/ml To A Base Consisted lOOgm Of 70% Vasiline In Oily Solution(Parafin, Almond Oil, Bees Wax And Perfume). The Ointment Has Ability To Revitalize The Skin, Decrease The Wrinkles In Three Months Time.
3- The New Ointment (SE Care2) The High Concentration Version Formed By Adding Two Substanses, Substance 1 Which Is lgm Vitamin E describes a family of eight antioxidants, four tocopherols, alpha-, beta-, gamma- and delta-, and four tocotrienols (also alpha-, beta-, gamma- and delta-),Substance2 Which Is 0,5 gm Protein-free haemodialysate of calves' blood (Bos Taurus)chemically and biologically standardized 42.5 mg/Ml To A Base Consisted lOOgm Of 70% Vasiline In Oily Solution(Parafin, Almond Oil, Bees Wax And Perfume). The Ointment Has Ability To Stimulate Hair Growth In Three Months Time And Promote Healing Of Persistant Ulcer In Two Weeks Time.
EP08706951.4A 2008-01-30 2008-02-21 Ointment on the basis of a dialysate of calves' blood. Withdrawn EP2240188A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EG2008010173 2008-01-30
PCT/EG2008/000010 WO2009095028A1 (en) 2008-01-30 2008-02-21 Ointment on the basis of a dialysate of calves' blood.

Publications (2)

Publication Number Publication Date
EP2240188A1 true EP2240188A1 (en) 2010-10-20
EP2240188A4 EP2240188A4 (en) 2013-05-01

Family

ID=40912296

Family Applications (1)

Application Number Title Priority Date Filing Date
EP08706951.4A Withdrawn EP2240188A4 (en) 2008-01-30 2008-02-21 Ointment on the basis of a dialysate of calves' blood.

Country Status (3)

Country Link
EP (1) EP2240188A4 (en)
JP (1) JP2011510935A (en)
WO (1) WO2009095028A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105456166A (en) * 2015-12-21 2016-04-06 太仓张根木生物科技有限公司 Anti-wrinkle moisturizing toner

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63135309A (en) * 1986-11-28 1988-06-07 Shiseido Co Ltd Skin external preparation
JPH0491009A (en) * 1990-08-07 1992-03-24 Kanebo Ltd Skin cosmetic
JPH06128138A (en) * 1992-10-15 1994-05-10 Kyowa Hakko Kogyo Co Ltd Cosmetic
US5486353A (en) * 1993-09-29 1996-01-23 Solco Basel Ag Antisun product
DE10156297A1 (en) * 2001-11-19 2003-05-28 Henkel Kgaa Skin protectant, especially hand cream, which remains in place for long periods comprising paraffin oils, petrolatum, carnauba wax and optionally silicon oils and/or additional waxes
US20040191196A1 (en) * 2002-12-16 2004-09-30 Dov Tamarkin Novel conjugate compounds and dermatological compositions thereof
US20060134046A1 (en) * 2004-12-21 2006-06-22 Ibrahim Hanna Skin nourishing and moisturizing cream

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2757937A1 (en) * 1977-12-24 1979-06-28 Byk Gulden Lomberg Chem Fab Skin-care cosmetics - contg. calf's blood haemodialysate
DE3042999C2 (en) * 1980-11-14 1984-05-10 Solco Basel AG, Birsfelden Process for the production of a skin cosmetic
DE4113346A1 (en) * 1991-04-24 1992-10-29 Lang Erich Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63135309A (en) * 1986-11-28 1988-06-07 Shiseido Co Ltd Skin external preparation
JPH0491009A (en) * 1990-08-07 1992-03-24 Kanebo Ltd Skin cosmetic
JPH06128138A (en) * 1992-10-15 1994-05-10 Kyowa Hakko Kogyo Co Ltd Cosmetic
US5486353A (en) * 1993-09-29 1996-01-23 Solco Basel Ag Antisun product
DE10156297A1 (en) * 2001-11-19 2003-05-28 Henkel Kgaa Skin protectant, especially hand cream, which remains in place for long periods comprising paraffin oils, petrolatum, carnauba wax and optionally silicon oils and/or additional waxes
US20040191196A1 (en) * 2002-12-16 2004-09-30 Dov Tamarkin Novel conjugate compounds and dermatological compositions thereof
US20060134046A1 (en) * 2004-12-21 2006-06-22 Ibrahim Hanna Skin nourishing and moisturizing cream

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Deite C.: "A Practical Treatise on the Manufacture of Perfumery:", , 1892, XP002694059, Philadelphia Retrieved from the Internet: URL:http://ia700504.us.archive.org/8/items/practicaltreatis00deitrich/practicaltreatis00deitrich.pdf [retrieved on 2013-03-14] *
See also references of WO2009095028A1 *

Also Published As

Publication number Publication date
WO2009095028A1 (en) 2009-08-06
EP2240188A4 (en) 2013-05-01
JP2011510935A (en) 2011-04-07

Similar Documents

Publication Publication Date Title
Farris Topical vitamin C: a useful agent for treating photoaging and other dermatologic conditions
Ehrlich et al. Improvement in the appearance of wrinkles with topical transforming growth factor β1 and L-ascorbic acid
TW200412992A (en) Compositions containing peptide copper complexes and phytochemical compounds, and methods related thereto
GB2451224A (en) Cosmetic composition comprising an exfoliant, astringent, antioxidant and moisturiser
KR100673044B1 (en) The composition for external use by percutaneous administration
KR20190013101A (en) Composition for preventing or treating scar
CN113645985A (en) Method, composition, sheet for therapeutic skin treatment
US20110166222A1 (en) Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
CN110559226A (en) Whitening lotion and preparation method thereof
KR20170130742A (en) Cosmetic Composition For Regenerating skin
US20130202540A1 (en) Method for repair of acute and chronic injury, such as burned and photodamaged skin
Fibrich et al. Fighting the inevitable: skin aging and plants
EP2240188A1 (en) Ointment on the basis of a dialysate of calves' blood.
CN113693966B (en) Whitening spot-lightening and brightening cream and preparation method thereof
Mohan et al. Dermaroller in dermatology and cosmetology
RU2352329C1 (en) Method of treatment of age and cosmetic defects of face skin
US8969411B2 (en) Vitamin C composition for use in the prevention and treatment of stretch other skin conditions and methods of using the same
KR20130017871A (en) Cosmetic composition containing linolenic acid for treating vitiligo
KR102113317B1 (en) Composition for preventing or treating scar
Singh-Behl et al. Chemical peels
De Padova et al. Biorevitalization and combination techniques
Fernandes Evolution of cosmeceuticals and their application to skin disorders, including aging and blemishes
CN116035997A (en) Preparation process and application method of pure natural freckle-removing whitening liquid
KR20230147909A (en) Method of removing keratin of eczema foot
Jung et al. Skin aging: pathogenesis, prevention and treatment

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20100728

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA MK RS

DAX Request for extension of the european patent (deleted)
RIC1 Information provided on ipc code assigned before grant

Ipc: A61Q 7/00 20060101ALI20130321BHEP

Ipc: A61K 8/98 20060101ALI20130321BHEP

Ipc: A61K 31/355 20060101ALI20130321BHEP

Ipc: A61Q 19/08 20060101ALI20130321BHEP

Ipc: A61K 35/14 20060101AFI20130321BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20130403

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20130903